Navigation Links
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
Date:4/15/2009

M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

(PRWEB) April 15, 2009 -- M2S Inc., a clinical technology organization providing image management services for biopharmaceutical and medical device clinical trials and clinical data registries, announced today that it has named Jeffrey Yablon as its new Senior Vice President, Business Development.

Mr. Yablon brings over 20 years of experience in the life sciences industry, including senior management roles in pharmaceuticals, drug safety, laboratory management, clinical research, medical imaging and clinical technology. Before joining M2S, Mr. Yablon held the position of Vice President, Sales and Marketing with Sciformix Corporation, a knowledge process outsourcing organization providing pharmacovigilance services to biopharmaceutical and biotech companies. Prior to that position, he held the position of Vice President of Global Business Development at Perceptive Informatics, the technology division of Parexel International. He was also Chief Operating Officer at ICON Laboratories, a division of ICON Plc. Mr. Yablon is a founder of several companies as well as a current instructor and course director at Stony Brook University, Center for Biotechnology in Stony Brook, NY. He began his career at TAP Pharmaceuticals and Abbott Laboratories, where he held various positions of increasing responsibility in sales and marketing. Mr Yablon received his MBA from the executive program at Fairleigh Dickinson University. In his new role at M2S, Mr. Yablon will be responsible for managing all M2S sales efforts and overseeing the marketing strategy of the rapidly expanding Clinical Trials Imaging, Endovascular, and Clinical Data Registries services, in addition to the development and implementation of strategic partnerships.

"Jeffrey has extensive experience and in-depth industry knowledge of the clinical research and informatics industry, and therefore will be a great asset to our organization," said M2S's CEO, Wes Chapman. "He is a well respected and established leader in the clinical trials community, and our clients will greatly benefit from his understanding of their drug and medical device challenges in the new economy. His leadership, combined with the M2S clinical expertise, highly efficient processes and advanced technologies, will continue to advance our market share in the clinical trials and patient data registries markets."

Mr. Yablon says, "I am excited to be part of a truly differentiated Clinical Technology Organization that is able to combine best-in-class technical infrastructure with superior clinical acumen that will directly impact cost, quality, and efficiency to benefit our clients. I look forward to playing a key role in the growth of M2S."

About M2S
M2S is a Clinical Technology Organization (CTO), providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as clinical registry databases. For the past 10 years, M2S has managed, under protocol, over 150 million images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com

###

Read the full story at http://www.prweb.com/releases/clinical/trials/prweb2324234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Frost & Sullivan Recognizes CRi for Innovations Leading to Personalized Medicine
2. Western Governors University to Launch Nations First Competency-Based B.S. in Nursing Leading to RN Licensure
3. HealthEquity, a Leading Healthcare Account Administrator, Licenses Thomson Reuters Information Solutions to Help People Make Better Healthcare Decisions
4. Nobel Prize Winner Professor Muhammad Yunus Leading Delegation From Bangladesh to World Health Care Congress to Advance Affordable Health Care Innovations
5. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
6. New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products
7. The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice
8. Versus Technology to Showcase Leading Enterprise Patient and Clinical Workflow Solutions at HIMSS 2009
9. Last step leading to blood cell formation elucidated
10. Leading Autism Care Provider Invites MPs to Meet Residents and Staff for World Autism Awareness Day
11. Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Leading Clinical Technology Organization M2S Inc. Announces the Appointment of Jeffrey Yablon as Senior Vice President, Business Development
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: